C16:0-ceramide signals insulin resistance Journal Article


Authors: Hla, T.; Kolesnick, R.
Article Title: C16:0-ceramide signals insulin resistance
Abstract: A substantive literature has accumulated implicating sphingolipids, in particular ceramides, as mediators of insulin resistance in metabolic syndrome. Thanks to recent technical advances in mouse genetics and lipidomics, two independent laboratories identify the same sphingolipid, C16:0-ceramide, as principal mediator of obesity-related insulin resistance (Turpin et al.; 2014; Raichur et al.; 2014).
Journal Title: Cell Metabolism
Volume: 20
Issue: 5
ISSN: 1550-4131
Publisher: Elsevier Inc.  
Date Published: 2014-11-04
Start Page: 703
End Page: 705
Language: English
DOI: 10.1016/j.cmet.2014.10.017
PROVIDER: scopus
PUBMED: 25440051
PMCID: PMC4393079
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard N Kolesnick
    299 Kolesnick